Analysts Gordon Johnson and Jim Chanos are intensifying their critical stance on Tesla Inc. TSLA, citing significant challenges in the electric vehicle manufacturer’s performance and market position.
What Happened: Johnson of GLJ Research launched a scathing critique on social media platform X, highlighting Tesla’s deteriorating financial metrics. “Tesla’s margins are imploding,” Johnson wrote, pointing to frequent discounts and what he describes as collapsing brand and market share across global markets including China, the United States, Europe, Canada, and Australia.
Johnson’s analysis suggests Tesla trades at 127x 2025 estimated adjusted earnings per share, compared to the Magnificent Seven tech stocks’ average of 32x. He emphasizes that Tesla is not truly a tech stock, with approximately 90% of its revenue derived from automobile sales.
Short seller Chanos amplified concerns by highlighting a 35% year-to-date sales drop in San Diego County, which he characterized as “material.” This figure significantly diverges from S&P Mobility’s more conservative estimate of an 11% sales decline.
Why It Matters: The ongoing debate between Johnson and Fox Business Senior Correspondent Charles Gasparino has further spotlighted Tesla’s challenges. Johnson notes that since 2022, Tesla’s stock has declined 30.4% while the S&P 500 has increased 20.2% during the same period.
Tesla’s upcoming first quarter of 2025 delivery report is anticipated to provide further insight into the company’s current market performance, with investors closely monitoring potential indicators of the company’s strategic direction and financial health.
Price Action: Tesla’s stock closed at $278.39, up 11.93% for the day. In after-hours trading, the stock rose an additional 1.43%, according to data from Benzinga Pro.
Read Next:
Image via Shutterstock
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.